ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for discussion Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.

ATHX Athersys Inc

0,1018
0,00 (0,00%)
Zuletzt aktualisiert: 02:00:00
Verzögert um 15 Minuten
Name Symbol Markt Aktientyp
Athersys Inc ATHX NASDAQ Common Stock
  Änderung Änderung % Aktuell Zeit
0,00 0,00% 0,1018 02:00:00
Handelsbeginn Niedrig Hoch Schlusskurs Handelsende
0,1018
more quote information »

Aktuelle News

Datum Zeit Quelle Überschrift
08.1.202413:31EDGAR2Form 8-K - Current report
22.12.202323:09EDGAR2Form 8-K - Current report
21.12.202317:37EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16.11.202314:35EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
18.10.202314:00EDGAR2Form 8-K - Current report
16.10.202322:52BWAthersys Extends Near Term Liquidity with Proceeds from..
12.10.202315:28EDGAR2Form 8-K - Current report
11.10.202315:27EDGAR2Form 8-K - Current report
10.10.202314:30BWAthersys Reports Interim Analysis Results of MASTERS-2..
06.10.202323:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06.10.202323:28EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03.10.202322:41EDGAR2Form 8-K - Current report
03.10.202322:30BWAthersys Licenses its Animal Health Assets to Ardent Animal..
02.10.202323:05EDGAR2Form 8-K - Current report
02.10.202323:04BWAthersys Director Jane Wasman Appointed Board Chair
25.9.202322:36EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
22.9.202306:15EDGAR2Form EFFECT - Notice of Effectiveness
19.9.202318:28EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19.9.202303:35EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
19.9.202303:04EDGAR2Form 8-K - Current report
14.9.202317:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14.9.202316:41EDGAR2Form 3 - Initial statement of beneficial ownership of..
13.9.202323:13EDGAR2Form S-3 - Registration statement under Securities Act of..
11.9.202314:46EDGAR2Form 8-K - Current report
06.9.202320:45BWGrant Awarded to Newcastle University to Research Athersys’..
21.8.202320:36EDGAR2Form 424B4 - Prospectus [Rule 424(b)(4)]
18.8.202316:14EDGAR2Form 8-K - Current report
18.8.202303:30BWAthersys, Inc. Announces Pricing of $3.5 Million Public..
17.8.202322:15EDGAR2Form DEF 14A - Other definitive proxy statements
16.8.202323:05EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
16.8.202323:01BWAthersys Reports Second Quarter 2023 Financial Results and..
11.8.202314:19EDGAR2Form 8-K - Current report
11.8.202314:00BWAthersys Appoints Neema Mayhugh, PhD to its Board of..
10.8.202323:03EDGAR2Form 8-K - Current report
08.8.202314:02EDGAR2Form 8-K - Current report
07.8.202323:02EDGAR2Form S-1/A - General form for registration of securities..
31.7.202319:38BWAthersys to Host Business Update Conference Call on August..
31.7.202314:01EDGAR2Form 8-K - Current report
26.7.202315:19EDGAR2Form S-1/A - General form for registration of securities..
14.7.202322:31EDGAR2Form S-1 - General form for registration of securities under..
14.7.202322:16EDGAR2Form 8-K/A - Current report: [Amend]
06.7.202315:53EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06.7.202315:51EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05.7.202320:04EDGAR2Form 8-K - Current report
01.6.202322:40BWPatient Enrollment Begins in Third and Final Cohort of the..
23.5.202314:30BWAthersys Restructures Debt with Supplier
18.5.202315:58BWAthersys Reports First Quarter 2023 Financial Results and..
08.5.202315:49BWAthersys to Participate in Three Upcoming Conferences
01.5.202314:30BWAthersys to Participate in The Cellular Therapies and..

Kürzlich von Ihnen besucht

Delayed Upgrade Clock